Hepion Pharmaceuticals's total assets for Q2 2025 were $4.51M, a decrease of -28.69% from the previous quarter. HEPA total liabilities were $708.53K for the fiscal quarter, a -70.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.